Service contract for illumina hiseq and two nextseq

Ended Purchase Order Awarded Last action

Contract number
HHSN261201500223P
Awardee
Awarding agency
Obligated
$60,292

Award facts

Opportunity
Contract value 100% obligated
$60,292.06 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$1
Original award $60,293

About this award

The National Cancer Institute awarded a purchase order to Illumina, Inc. valued at $60,292.06 on August 20, 2015, for service on Illumina HiSeq and two NextSeq sequencing instruments. Work is performed in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of February 19, 2016.

Quick answers

Who was awarded contract HHSN261201500223P?

HHSN261201500223P was awarded to Illumina, Inc. by National Cancer Institute (National Institutes of Health) on August 20, 2015.

How much is contract HHSN261201500223P worth?

The government has obligated $60,292 on HHSN261201500223P.

Was contract HHSN261201500223P competed?

The extent of competition for HHSN261201500223P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award